Royalty Pharma PLC

Royalty Pharma PLC Stock

43.55P/E
€27.48BMarket capitalisation
US$1.53Earnings
1.35 %Dividend yield

Current price

—
1D
1W
1M
3M
6M
1Y
3Y
Max

Company description

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

Royalty Pharma PLC is registered in the following country: United Kingdom (Exchange: USNASD).

Key metrics

Key metrics and master data for the Royalty Pharma PLC stock.

Market capitalisation
€27.48B
P/E
43.55
P/B
4.48
P/S
12.12
P/CF
11.05
Issued shares 445M Units

Return

Here you can see the performance of the Royalty Pharma PLC stock.

PeriodPerfor­mance
1 Week+0.08 %
1 Month+16.68 %
3 Months+24.17 %
6 Months+36.47 %
1 Year+61.98 %
YTD+38.59 %

Dividends

The Royalty Pharma PLC stock pays an annual dividend. With an (expected) annual dividend of £0.8529, the current stock price results in a dividend yield of 1.35 %.

Dividend typeAnnual dividend
(Expected) annual dividend £0.8529
Dividend yield 1.35 %

Splits

The table shows the splits of the Royalty Pharma PLC share.

DateRatio
No data available.

Which ETF contains the Royalty Pharma PLC stock?

The Royalty Pharma PLC stock is contained in a total of 0 ETFs with at least 1%. You can find a list of these ETFs in the following table. With —, Royalty Pharma PLC has the largest weight in .

Name
Weighting
Region
Country
TER
Replication
Volume (£m)

Frequently asked questions

Here you can find all answers to your questions about the Royalty Pharma PLC stock.

Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).

Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.

Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.